Senate Bill S3256B

2015-2016 Legislative Session

Establishes the sickle cell treatment act of 2016; appropriation

download bill text pdf

Sponsored By

Archive: Last Bill Status - In Senate Committee Finance Committee


  • Introduced
    • In Committee Assembly
    • In Committee Senate
    • On Floor Calendar Assembly
    • On Floor Calendar Senate
    • Passed Assembly
    • Passed Senate
  • Delivered to Governor
  • Signed By Governor

Do you support this bill?

Please enter your contact information

Home address is used to determine the senate district in which you reside. Your support or opposition to this bill is then shared immediately with the senator who represents you.

Optional services from the NY State Senate:

Create an account. An account allows you to officially support or oppose key legislation, sign petitions with a single click, and follow issues, committees, and bills that matter to you. When you create an account, you agree to this platform's terms of participation.

Include a custom message for your Senator? (Optional)

Enter a message to your senator. Many New Yorkers use this to share the reasoning behind their support or opposition to the bill. Others might share a personal anecdote about how the bill would affect them or people they care about.
Actions

Bill Amendments

co-Sponsors

2015-S3256 - Details

Current Committee:
Senate Finance
Law Section:
Appropriations
Laws Affected:
Amd §365, Soc Serv L; add Art 31 Title IV §3126, Pub Health L
Versions Introduced in Other Legislative Sessions:
2013-2014: S6239
2017-2018: S4054
2019-2020: S2281

2015-S3256 - Summary

Establishes the sickle cell treatment act of 2016; makes an appropriation of one million dollars.

2015-S3256 - Sponsor Memo

2015-S3256 - Bill Text download pdf

                            
                    S T A T E   O F   N E W   Y O R K
________________________________________________________________________

                                  3256

                       2015-2016 Regular Sessions

                            I N  S E N A T E

                            February 4, 2015
                               ___________

Introduced  by  Sen. SANDERS -- read twice and ordered printed, and when
  printed to be committed to the Committee on Finance

AN ACT to amend the social services law and the public  health  law,  in
  relation  to  establishing  the sickle cell treatment act of 2015; and
  making an appropriation therefor

  THE PEOPLE OF THE STATE OF NEW YORK, REPRESENTED IN SENATE AND  ASSEM-
BLY, DO ENACT AS FOLLOWS:

  Section  1.  This  act  shall be known and may be cited as the "sickle
cell treatment act of 2015".
  S 2. Legislative findings. The legislature hereby finds  and  declares
the following:
  (1)  Sickle  cell  disease  (SCD) is an inherited disease of red blood
cells that is a major health problem in the United States.
  (2) Approximately 100,000 Americans have SCD and  approximately  1,000
American  babies  are  born  with  the  disease each year. SCD also is a
global problem with close to  500,000  babies  born  annually  with  the
disease.
  (3)  In the United States, SCD is most common in African-Americans and
in those of Hispanic, Mediterranean, and Middle Eastern ancestry.  Among
newborn  American infants, SCD occurs in approximately 1 in 500 African-
Americans, 1 in 36,000 Hispanics, and 1 in 80,000 Caucasians.
  (4) More than 3,000,000 Americans, mostly African-Americans, have  the
sickle  cell  trait.  These Americans are healthy carriers of the sickle
cell gene who have inherited the normal hemoglobin gene from one  parent
and  the  sickle cell gene from the other parent. A sickle cell trait is
not a disease, but when both parents have the sickle cell  trait,  there
is  a 1 in 4 chance with each pregnancy that the child will be born with
SCD.
  (5) Children with SCD may exhibit frequent pain  episodes,  entrapment
of  blood  within  the  spleen,  severe anemia, acute lung complications
(acute chest syndrome), and priapism. During episodes  of  severe  pain,

 EXPLANATION--Matter in ITALICS (underscored) is new; matter in brackets
                      [ ] is old law to be omitted.
                                                           LBD04153-01-5
              

co-Sponsors

2015-S3256A - Details

Current Committee:
Senate Finance
Law Section:
Appropriations
Laws Affected:
Amd §365, Soc Serv L; add Art 31 Title IV §3126, Pub Health L
Versions Introduced in Other Legislative Sessions:
2013-2014: S6239
2017-2018: S4054
2019-2020: S2281

2015-S3256A - Summary

Establishes the sickle cell treatment act of 2016; makes an appropriation of one million dollars.

2015-S3256A - Sponsor Memo

2015-S3256A - Bill Text download pdf

                            
                    S T A T E   O F   N E W   Y O R K
________________________________________________________________________

                                 3256--A

                       2015-2016 Regular Sessions

                            I N  S E N A T E

                            February 4, 2015
                               ___________

Introduced  by  Sens.  SANDERS, DILAN -- read twice and ordered printed,
  and when printed to be committed to the Committee on Finance -- recom-
  mitted to the Committee on Finance in accordance with Senate  Rule  6,
  sec.  8  --  committee  discharged, bill amended, ordered reprinted as
  amended and recommitted to said committee

AN ACT to amend the social services law and the public  health  law,  in
  relation  to  establishing  the sickle cell treatment act of 2016; and
  making an appropriation therefor

  THE PEOPLE OF THE STATE OF NEW YORK, REPRESENTED IN SENATE AND  ASSEM-
BLY, DO ENACT AS FOLLOWS:

  Section  1.  This  act  shall be known and may be cited as the "sickle
cell treatment act of 2016".
  S 2. Legislative findings. The legislature hereby finds  and  declares
the following:
  (1)  Sickle  cell  disease  (SCD) is an inherited disease of red blood
cells that is a major health problem in the United States.
  (2) Approximately 100,000 Americans have SCD and  approximately  1,000
American  babies  are  born  with  the  disease each year. SCD also is a
global problem with close to  500,000  babies  born  annually  with  the
disease.
  (3)  In the United States, SCD is most common in African-Americans and
in those of Hispanic, Mediterranean, and Middle Eastern ancestry.  Among
newborn  American infants, SCD occurs in approximately 1 in 500 African-
Americans, 1 in 36,000 Hispanics, and 1 in 80,000 Caucasians.
  (4) More than 3,000,000 Americans, mostly African-Americans, have  the
sickle  cell  trait.  These Americans are healthy carriers of the sickle
cell gene who have inherited the normal hemoglobin gene from one  parent
and  the  sickle cell gene from the other parent. A sickle cell trait is
not a disease, but when both parents have the sickle cell  trait,  there
is  a 1 in 4 chance with each pregnancy that the child will be born with
SCD.

 EXPLANATION--Matter in ITALICS (underscored) is new; matter in brackets
                      [ ] is old law to be omitted.
                                                           LBD04153-02-6
              

co-Sponsors

2015-S3256B (ACTIVE) - Details

Current Committee:
Senate Finance
Law Section:
Appropriations
Laws Affected:
Amd §365, Soc Serv L; add Art 31 Title IV §3126, Pub Health L
Versions Introduced in Other Legislative Sessions:
2013-2014: S6239
2017-2018: S4054
2019-2020: S2281

2015-S3256B (ACTIVE) - Summary

Establishes the sickle cell treatment act of 2016; makes an appropriation of one million dollars.

2015-S3256B (ACTIVE) - Sponsor Memo

2015-S3256B (ACTIVE) - Bill Text download pdf

                            
                    S T A T E   O F   N E W   Y O R K
________________________________________________________________________

                                 3256--B

                       2015-2016 Regular Sessions

                            I N  S E N A T E

                            February 4, 2015
                               ___________

Introduced by Sens. SANDERS, DILAN, HAMILTON, HASSELL-THOMPSON, LATIMER,
  PARKER, PERKINS -- read twice and ordered printed, and when printed to
  be committed to the Committee on Finance -- recommitted to the Commit-
  tee  on  Finance in accordance with Senate Rule 6, sec. 8 -- committee
  discharged, bill amended, ordered reprinted as amended and recommitted
  to said committee  --  committee  discharged,  bill  amended,  ordered
  reprinted as amended and recommitted to said committee

AN  ACT  to  amend the social services law and the public health law, in
  relation to establishing the sickle cell treatment act  of  2016;  and
  making an appropriation therefor

  THE  PEOPLE OF THE STATE OF NEW YORK, REPRESENTED IN SENATE AND ASSEM-
BLY, DO ENACT AS FOLLOWS:

  Section 1. This act shall be known and may be  cited  as  the  "sickle
cell treatment act of 2016".
  S  2.  Legislative findings. The legislature hereby finds and declares
the following:
  (1) Sickle cell disease (SCD) is an inherited  disease  of  red  blood
cells and is a major health problem in the United States.
  (2) Approximately 100,000 Americans have SCD with approximately 10% of
SCD  patients residing in New York state (NYS).  In NYS, 1 in 1,146 live
births have sickle cell disease, with 12% of  NYS  sickle  cell  disease
births  in the Hispanic population. Higher birth rates for children with
sickle cell disease in NYS occur in mothers born outside of  the  United
States.    Approximately 1,000 American babies are born with the disease
each year. SCD also is a global problem with  close  to  500,000  babies
born annually with the disease.
  (3)  In the United States, SCD is most common in African-Americans and
in those of Hispanic, Mediterranean, and Middle Eastern ancestry.  Among
newborn  American  infants  nationally, SCD occurs in approximately 1 in
500 African-Americans, 1 in 36,000 Hispanics, and  1  in  80,000  Cauca-
sians.    In  NYS, sickle cell disease occurs in 1 in 230 live births to

 EXPLANATION--Matter in ITALICS (underscored) is new; matter in brackets
                      [ ] is old law to be omitted.
                                                           LBD04153-04-6
              

Comments

Open Legislation is a forum for New York State legislation. All comments are subject to review and community moderation is encouraged.

Comments deemed off-topic, commercial, campaign-related, self-promotional; or that contain profanity, hate or toxic speech; or that link to sites outside of the nysenate.gov domain are not permitted, and will not be published. Attempts to intimidate and silence contributors or deliberately deceive the public, including excessive or extraneous posting/posts, or coordinated activity, are prohibited and may result in the temporary or permanent banning of the user. Comment moderation is generally performed Monday through Friday. By contributing or voting you agree to the Terms of Participation and verify you are over 13.

Create an account. An account allows you to sign petitions with a single click, officially support or oppose key legislation, and follow issues, committees, and bills that matter to you. When you create an account, you agree to this platform's terms of participation.